Ordering
Available Variants25 mg
CHA.56170-25mg
Price
€284.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.56170-25mg | €284.00 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C19H16N8O·CH3SO3H |
|---|---|
| CAS Number | 956906-93-7 |
| Molecular Weight | 468.49 |
| NACRES | NA.77 |
| PubChem Substance ID | 329825271 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD17392584 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
PF-04217903, also known by its CAS number 956906-93-7, is a potent and selective inhibitor of the enzyme c-Jun N-terminal kinase 3. This compound has been investigated for its potential therapeutic applications, particularly in the treatment of neurodegenerative diseases and inflammatory disorders. The mechanism of action of PF-04217903 involves the reversible inhibition of JNK3, which plays a crucial role in stress signaling pathways. By inhibiting JNK3, PF-04217903 has been shown to reduce the phosphorylation of downstream targets, thereby mitigating the effects of stress and inflammation. Further research is needed to fully elucidate the pharmacological properties and potential clinical benefits of PF-04217903, but its selective inhibition of JNK3 makes it an interesting candidate for the development of novel therapeutic strategies. Its potential therapeutic applications are being explored in various preclinical studies.
